We utilize these PTBP2 splice maps to identify genetic etiologies of neurological disorders that may benefit from splice modulation and use such a map to guide steric-blocking oligonucleotides that disrupt PTBP2-dependent AS of the synaptic gene SYNGAP1 for potentially therapeutic upregulation. The gene discussed is SYNGAP1; the disease is nervous system disorder.